$RARE Ultragenyx Pharmaceutical Inc. Insider Trading Week 23/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. in week 23/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Grant | A | 0.00 | 3,000 | 0 | 47,924 | 44.9 K to 47.9 K (+6.68 %) |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | SULIMAN SHEHNAAZ | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | SULIMAN SHEHNAAZ | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,000 | 0 | 9,750 | 6.8 K to 9.8 K (+44.44 %) |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Grant | A | 0.00 | 3,000 | 0 | 9,750 | 6.8 K to 9.8 K (+44.44 %) |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Grant | A | 0.00 | 3,000 | 0 | 9,750 | 6.8 K to 9.8 K (+44.44 %) |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Grant | A | 0.00 | 3,000 | 0 | 14,750 | 11.8 K to 14.8 K (+25.53 %) |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Grant | A | 0.00 | 3,000 | 0 | 9,750 | 6.8 K to 9.8 K (+44.44 %) |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Grant | A | 0.00 | 3,000 | 0 | 7,875 | 4.9 K to 7.9 K (+61.54 %) |